The Journal of Immunology, Vol 152, Issue 9 4388-4396, Copyright © 1994 by American Association of Immunologists

ARTICLES

Antigen presentation is enhanced by targeting antigen to the Fc epsilon RII by antigen-anti-Fc epsilon RII conjugates

CM Squire, EJ Studer, A Lees, FD Finkelman and DH Conrad
Department of Microbiology and Immunology, Virginia Commonwealth University, Richmond 23298.

Targeting Ag to the Fc epsilon RII by Ag-specific IgE has been shown to be an efficient means of enhancing Ag presentation by B cells to Ag- specific T cells. To take advantage of the Fc epsilon RII as a targeting molecule and to investigate whether IgE was required for mediation of the enhanced stimulation, Ag was covalently coupled to anti-Fc epsilon RII by using heterobifunctional crosslinking reagents. These Ag-Ab conjugates were used with T cell lines specific for the Ags, OVA (BB6.5) or rabbit gamma-globulin (CDC35 and D1.6), and splenic B cells to examine both B cell and T cell proliferation in vitro. Significant presentation of Ag-anti-Fc epsilon RII conjugates was apparent at doses of Ag 1,000- to 10,000-fold lower than seen with unconjugated Ag alone. Ag presentation with the use of anti-Fc epsilon RII-Ag conjugates was as good as or better than conjugates with Ab to the adhesion molecule Pgp-1 or control Ab in T cell proliferation and better than those conjugates in B cell proliferation assays (10- to 100- fold). Anti-Fc epsilon RII-Ag conjugates were clearly more effectively presented than Ag-anti-Fc gamma RII conjugates (> 100-fold). Mouse Fc epsilon RII is presently known to be expressed on B cells and follicular dendritic cells and these in vitro results suggest that the conjugates would be useful tools for investigating the role of IgE- mediated B cell Ag presentation in vivo. BALB/c mice immunized with OVA- anti-Fc epsilon RII conjugates made a quite significant OVA-specific IgG1 response and a detectable IgE response. No detectable Ab was produced in response to OVA alone and a minimal response was seen when an isotype-matched control conjugate was used. Thus, the results indicate that Fc epsilon RII targeting is operative both in vivo and in vitro.

This article has been cited by other articles:

				M. A. Kilmon, R. Ghirlando, M.-P. Strub, R. L. Beavil, H. J. Gould, and D. H. Conrad Regulation of IgE Production Requires Oligomerization of CD23 J. Immunol., September 15, 2001; 167(6): 3139 - 3145. [Abstract] [Full Text] [PDF]

				E. Reali, J. W. Greiner, A. Corti, H. J. Gould, F. Bottazzoli, G. Paganelli, J. Schlom, and A. G. Siccardi IgEs Targeted on Tumor Cells: Therapeutic Activity and Potential in the Design of Tumor Vaccines Cancer Res., July 1, 2001; 61(14): 5517 - 5522. [Abstract] [Full Text] [PDF]

				M. Payet-Jamroz, S. L. T. Helm, J. Wu, M. Kilmon, M. Fakher, A. Basalp, J. G. Tew, A. K. Szakal, N. Noben-Trauth, and D. H. Conrad Suppression of IgE Responses in CD23-Transgenic Animals Is Due to Expression of CD23 on Nonlymphoid Cells J. Immunol., April 15, 2001; 166(8): 4863 - 4869. [Abstract] [Full Text] [PDF]

				A.B. Kay Allergy and Allergic Diseases- First of Two Parts N. Engl. J. Med., January 4, 2001; 344(1): 30 - 37. [Full Text] [PDF]

				S. Gustavsson, S. Wernersson, and B. Heyman Restoration of the Antibody Response to IgE/Antigen Complexes in CD23-Deficient Mice by CD23+ Spleen or Bone Marrow Cells J. Immunol., April 15, 2000; 164(8): 3990 - 3995. [Abstract] [Full Text] [PDF]

				R. J. J. van Neerven, T. Wikborg, G. Lund, B. Jacobsen, A. Brinch-Nielsen, J. Arnved, and H. Ipsen Blocking Antibodies Induced by Specific Allergy Vaccination Prevent the Activation of CD4+ T Cells by Inhibiting Serum-IgE-Facilitated Allergen Presentation J. Immunol., September 1, 1999; 163(5): 2944 - 2952. [Abstract] [Full Text] [PDF]

				M. Cernadas, G. T. De Sanctis, S. J. Krinzman, D. A. Mark, C. E. Donovan, J. A. Listman, L. Kobzik, H. Kikutani, D. C. Christiani, D. L. Perkins, et al. CD23 and Allergic Pulmonary Inflammation: Potential Role as an Inhibitor Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 1 - 8. [Abstract] [Full Text]

				O. Munoz, C. Brignone, N. Grenier-Brossette, J.-Y. Bonnefoy, and J.-L. Cousin Binding of Anti-CD23 Monoclonal Antibody to the Leucine Zipper Motif of Fcepsilon RII/CD23 on B Cell Membrane Promotes Its Proteolytic Cleavage. EVIDENCE FOR AN EFFECT ON THE OLIGOMER/MONOMER EQUILIBRIUM J. Biol. Chem., November 27, 1998; 273(48): 31795 - 31800. [Abstract] [Full Text] [PDF]

				S. Gustavsson, S. Hjulstrom-Chomez, B.-M. Lidstrom, N. Ahlborg, R. Andersson, and B. Heyman Impaired Antibody Responses in H-2Ab Mice J. Immunol., August 15, 1998; 161(4): 1765 - 1771. [Abstract] [Full Text] [PDF]

				M. Leonetti, R. Thai, J. Cotton, S. Leroy, P. Drevet, F. Ducancel, J. C. Boulain, and A. Menez Increasing Immunogenicity of Antigens Fused to Ig-Binding Proteins by Cell Surface Targeting J. Immunol., April 15, 1998; 160(8): 3820 - 3827. [Abstract] [Full Text] [PDF]